Skip to main content
. 2021 Mar 25;127(13):2262–2270. doi: 10.1002/cncr.33492

Figure 1.

Figure 1

The most common classes of drugs found in malignant melanoma clinical trials are shown according to the number of trials between December 1, 2017 and September 1, 2019. IT indicates immunotherapy; TT, targeted therapy.